Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    63,569.13
    -1,179.50 (-1.82%)
     

  • CMC Crypto 200

    1,325.76
    -70.78 (-5.07%)
     

  • S&P 500

    5,110.35
    +61.93 (+1.23%)
     

  • Dow

    38,302.76
    +216.96 (+0.57%)
     

  • Nasdaq

    15,963.41
    +351.65 (+2.25%)
     

  • Gold

    2,344.60
    +2.10 (+0.09%)
     

  • Crude Oil

    83.84
    +0.27 (+0.32%)
     

  • 10-Yr Bond

    4.6710
    -0.0350 (-0.74%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Credit Suisse Sticks to Their Hold Rating for Covetrus Inc

Investing.com
·1-min read


Credit Suisse (SIX:CSGN) analyst Erin Wright maintained a Hold rating on Covetrus (NASDAQ:CVET) Inc on Thursday, setting a price target of $10, which is approximately 17.90% below the present share price of $12.18.

Wright expects Covetrus Inc to post earnings per share (EPS) of -$0.74 for the second quarter of 2020.

The current consensus among 1 TipRanks analysts is for a Hold rating of shares in Covetrus, with an average price target of $10.
The analysts price targets range from a high of $10 to a low of $10.

In its latest earnings report, released on 12/31/2019, the company reported a quarterly revenue of $1.01 billion and a net profit of -$26 million. The company's market cap is $1.36 billion.

ADVERTISEMENT

According to TipRanks.com, Credit Suisse analyst Erin Wright is a 5-star analyst with an average return of 8.6% and a 61.8% success rate.

Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.